Compositions and methods for inhibiting arginase activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11021495
APP PUB NO 20200339607A1
SERIAL NO

16792186

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure relates to a novel class of compounds that exhibit activity inhibitory activity toward arginase, and pharmaceutical compositions comprising the compounds of the disclosure. Also provided herein are methods of treating cancer with the arginase inhibitors of the disclosure.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PRECISION PHARMACEUTICALS INC601 CALIFORNIA STREET SUITE 620 SAN FRANCISCO CA 94108

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Billedeau, Roland J Santa Clara, US 15 51
Chen, Lijing Cupertino, US 31 307
Jagdmann,, Jr Gunnar E Branford, US 4 18
Li, Jim San Francisco, US 63 978
Petersen, Lene Raunkjær Værløse, DK 3 18
Sjogren, Eric B Mountain View, US 39 434
Stanton, Timothy F Daly City, US 11 93
Van, Zandt Michael Guilford, US 28 263
Whitehouse, Darren Westbrook, US 28 356

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 1, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 1, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00